Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · The Lancet · 395 citations
https://doi.org/10.1016/s0140-6736(22)00519-0
T
Tilak Tejomurtula
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
456
Citations
3
h-index
3
i10-index
Tilak Tejomurtula is an academic researcher. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 3, co-authored 3 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat